Status:
COMPLETED
Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis
Lead Sponsor:
Eurasian Association of Therapists
Conditions:
Polyvascular Disease
Atherosclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Аn international, multicenter, non-interventional real-life clinical practice Register studying the Actual therapeutic patient population with Multifocal Atherosclerosis in the Russian Federation and ...
Detailed Description
Information on demographics, comorbidities, methods for diagnosing multifocal atherosclerosis (MFA), prescribed therapy, and outcomes will be identified via medical records analysis. Results of arteri...
Eligibility Criteria
Inclusion
- Men or women aged 18 and older at the time of data registration; Presence of 2 or more of the following factors
- Coronary arteries atherosclerosis (atherosclerosis revealed by means of coronary angiography and/or a history of type I myocardial infarction and/or elective PCI and/or CABG and/or angina pectoris with ischemia according to stress test results, history of CHD);
- Lower extremity arteries atherosclerosis (atherosclerotic plaques revealed by ultrasound, and/or ABI \<0.9, and/or a history of revascularization, and/or a history of amputation associated due to chronic lower extremities arterial insufficiency);
- Atherosclerosis of brachiocephalic arteries or renal arteries (presence of atherosclerotic plaques according to US data and/or history of revascularization and/or history of atherothrombotic stroke or TIA in the absence of known AF);
- Atherosclerosis of renal arteries or abdominal aorta (presence of atherosclerotic plaques according to US data and/or history of revascularization).
- Presence of one or more of the following atherosclerotic risk factors:
- Anamnestic data on dyslipidemia with LDL cholesterol levels above 4.9 mmol/L or total cholesterol levels above 8.0 mmol/L;
- Presence of confirmed familial hypercholesterolemia;
- Current smoker status or history of smoking;
- Overweight (BMI≥ 25 kg/m2);
- Presence of arterial hypertension;
- Presence of established type 2 diabetes mellitus;
- Presence of an established diagnosis of prediabetes;
- Presence of CKD stage 3a and higher (GFR \<60 ml / min / 1.73 m2).
Exclusion
- Life expectancy less than 1 year;
- Patient refusal to participate in the Register
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
3059 Patients enrolled
Trial Details
Trial ID
NCT05189847
Start Date
February 1 2022
End Date
January 31 2024
Last Update
June 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eurasian Association of Therapists
Moscow, Russia